CHSH has advised on Austrian legal aspects of LifeNet Health’s recently concluded acquisition of Krems-based tissue bank AlloTiss from Drs. Karl Kaudela und Ursula Burner. CHSH collaborated with U.S. firm Kaufman & Canoles to facilitate the transaction, while the sellers were advised by EYLaw.
CHSH describes LifeNet Health, which is headquartered in Virginia, in the United States, as "the world's most-trusted provider of transplant solutions and is a leader in regenerative medicine" and reports that "its grafts are distributed in more than 25 countries on five continents."
Founded in 2014, AlloTiss is a trusted member of the biomedical community, with partnerships throughout the European Union. According to CHSH, "LifeNet Health will leverage AlloTiss’s existing logistical infrastructure in Europe to accelerate the process of establishing its presence in Vienna, which is planned for completion in summer 2017."
CHSH Partner Thomas Trettnak, who headed the firm's team of four lawyers on the deal, said, “it was a true pleasure to support LifeNet Health and their US counsel in this exciting overseas transaction. Knowing that it will create the foundation in Europe for saving lives, restoring health, and giving hope to thousands each year makes us proud of being part of the team.”
The EYLaw team advising the sellers was led by Partner Mario Gall, supported by Associate Fabian Spendel.
